Companies /Healthcare

Shattuck Labs Inc

NASDAQ: STTK Biotechnology

$6.91

▲ $0.04 (+0.58%) today

Markets closed · 4:40am ET

Today · % change

Fundamentals

Market Cap

$689.5M

Revenue (TTM)

$1.0M

EPS (TTM)

$-0.44

52-Week Range

$1 – $8

Street Target

$14.67

About Shattuck Labs

Shattuck Labs Inc is a biotechnology firm based in Austin, Texas, focusing on creating treatments for cancer and autoimmune diseases. With its flagship product, SL-172154, currently undergoing Phase 1 clinical trials aimed at tackling ovarian, fallopian tube, and peritoneal cancers, the company represents a pioneering force in the medical research field since its inception in 2016.

STTK Coverage

8:00am ET

Investing

Here Are Friday’s Top Wall Street Analyst Research Calls: Albertsons, Blue Owl Capital, Cleveland-Cliffs, Chime Financial, Digital Realty, Dover, PayPal Holdings, SpaceX, and More

Markets took a brutal hit Thursday as oil prices, surging interest rates, and Middle East tensions sent every major index deep into the red. See which stocks analysts are upgrading, downgrading, and…

ACI CAKE CHYM

Lee Jackson

8:45am ET

Investing

Elon Musk Leads Insider Buying Wave

The highlight of recent insider buying is an enormous purchase of Tesla shares by CEO Elon Musk. But it wasn't the only notable buy in the past week or so.

CELC CGON REZI

Trey Thoelcke